glp 1 and dementia Can GLP-1 agonists SGLT-2 inhibitors decrease risk?, Two recent JAMA Neurology studies examined the association., 🔗 Read more via our link in bio Frontiers | The mechanism and

Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis

[Google Scholar] 19.Graaf C de, Donnelly D., Wootten D., Lau J., Sexton P.M., Miller L.J., et al

Furthermore, semaglutide is superior to other GLP-1R agonists, such as liraglutide, which uses similar pharmacological mechanisms but only has a half-life of 13 h and therefore has to be injected subcutaneously daily

[DOI] [PMC free article] [PubMed] [Google Scholar] Mller FS, Hegelund ER

Phase 4 (Post-Marketing): Monitors long-term safety, effectiveness, and rare side effects after the drug reaches the market

When will it be available